Login / Signup

Viremia and viruria of trichodysplasia spinulosa-associated polyomavirus before the development of clinical disease in a kidney transplant recipient.

Ligia Camera Camera PierrottiPaulo Roberto Palma UrbanoLuiz Henrique da Silva NaliCamila Malta RomanoCamila da Silva BicalhoMarcelo ArnoneNeusa Sakai ValenteCláudio Sérgio PannutiElias David-NetoLuiz Sérgio Azevedo
Published in: Transplant infectious disease : an official journal of the Transplantation Society (2019)
Trichodysplasia spinulosa (TS) is a rare disease associated with immunosuppression and induced by a polyomavirus denominated Tricodisplasia Polyomavirus (TSPyV). We report a case of TS 6 months after kidney transplantation in a 65 years-old woman under immunosuppression therapy with prednisone, mycophenolate and tacrolimus. The patient developed follicular papules on the face with a thickening of the skin and alopecia of the eyebrows, leading to distortion of the face and a leonine appearance characteristic of the disease. The skin biopsy confirmed the clinical diagnosis and the presence of TSPyV DNA in the skin was detected. Staining for SV40 was positive. Immunosuppression was changed: mycophenolate was withdrawn, tacrolimus reduced and everolimus added. Intravenous cidofovir and later on leflunomide were added. Although the literature has reported clinical success with topical cidofovir, we were unable to use it because this drug is not available. There was an improvement of skin lesions and on cosmetic appearance. The patient had three rejections (one clinically diagnosed and two other biopsy proven), progressed with renal failure and graft loss. Retrospective analysis of stored urine and blood samples detected TSPyV DNA in some of those samples two months before the TS clinical development. This case highlights the TSPyV detection in blood and urine samples before the development of skin lesions.
Keyphrases
  • wound healing
  • soft tissue
  • case report
  • emergency department
  • single molecule
  • low dose
  • quantum dots
  • adverse drug
  • circulating tumor cells